Literature DB >> 12152671

Association of gammaA/gamma' fibrinogen levels and coronary artery disease.

Rehana S Lovely1, Lisa A Falls, Hamid A Al-Mondhiry, Charles E Chambers, Gary J Sexton, Hanyu Ni, David H Farrell.   

Abstract

GammaA/gamma' fibrinogen is a fibrinogen isoform that constitutes about 15% of total plasma fibrinogen. This isoform contains an additional binding site for zymogen factor XIII and for active thrombin, and forms fibrin clots that are resistant to fibrinolysis in vitro. Little is known about the variability of gammaA/gamma' fibrinogen levels in human populations, whereas total fibrinogen levels are known to increase with age and are higher in women than in men. In this report, evidence is presented that, in contrast to total fibrinogen levels, gammaA/gamma' fibrinogen levels showed no significant association with age or gender in a population of normal blood donors. A study of gammaA/gamma' fibrinogen levels in patients undergoing coronary angiography also showed that gammaA/gamma' fibrinogen levels were higher on average in coronary artery disease patients than in patients without coronary artery disease, and that this association was independent of total fibrinogen levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12152671

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  28 in total

1.  Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease.

Authors:  Rehana S Lovely; Steven C Kazmierczak; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; David H Farrell
Journal:  Clin Chem       Date:  2010-03-26       Impact factor: 8.327

2.  Association between γ' fibrinogen levels and inflammation.

Authors:  Kristine S Alexander; Theresa E Madden; David H Farrell
Journal:  Thromb Haemost       Date:  2010-12-21       Impact factor: 5.249

Review 3.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

4.  Assessment of genetic determinants of the association of γ' fibrinogen in relation to cardiovascular disease.

Authors:  Rehana S Lovely; Qiong Yang; Joseph M Massaro; Jing Wang; Ralph B D'Agostino; Christopher J O'Donnell; Jackilen Shannon; David H Farrell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-14       Impact factor: 8.311

5.  Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.

Authors:  Paul Y Kim; Trang T Vu; Beverly A Leslie; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

6.  Differential regulation of fibrinogen γ chain splice isoforms by interleukin-6.

Authors:  Chantelle M Rein-Smith; Nathan W Anderson; David H Farrell
Journal:  Thromb Res       Date:  2012-10-01       Impact factor: 3.944

7.  Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.

Authors:  Michelle A Berny; Imke C A Munnix; Jocelyn M Auger; Saskia E M Schols; Judith M E M Cosemans; Peter Panizzi; Paul E Bock; Steve P Watson; Owen J T McCarty; Johan W M Heemskerk
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

8.  Lack of association of plasma gamma prime (γ') fibrinogen with incident cardiovascular disease.

Authors:  Duke Appiah; Susan R Heckbert; Mary Cushman; Bruce M Psaty; Aaron R Folsom
Journal:  Thromb Res       Date:  2016-04-28       Impact factor: 3.944

9.  Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin.

Authors:  Shahid M Nimjee; Sabah Oney; Zoya Volovyk; Kristin M Bompiani; Steve B Long; Maureane Hoffman; Bruce A Sullenger
Journal:  RNA       Date:  2009-10-21       Impact factor: 4.942

10.  Fibrinogen Hershey IV: a novel dysfibrinogen with a gammaV411I mutation in the integrin alpha(IIb)beta(3) binding site.

Authors:  Veronica H Flood; Hamid A Al-Mondhiry; Chantelle M Rein; Kristine S Alexander; Rehana S Lovely; Kelley M Shackleton; Larry L David; David H Farrell
Journal:  Thromb Haemost       Date:  2008-06       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.